跳转至内容
Merck
CN
  • AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines.

AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines.

Oral oncology (2014-12-17)
Tobias Ettl, Sandra Viale-Bouroncle, Matthias G Hautmann, Martin Gosau, Oliver Kölbl, Torsten E Reichert, Christian Morsczeck
摘要

Induction of apoptosis is a major mechanism of radiosensitivity in different types of cancer. In contrast, EGFR/PI3K/AKT signalling and recently the presence of so-called cancer stem cells are discussed as reasons for radioresistance. The study investigates mechanisms of apoptosis, key oncogenes of the PI3K/AKT pathway and the presence of cancer cells with stem cell properties during irradiation in two cell lines (PCI-9A, and PCI-15) of head and neck squamous cell carcinoma. WST-1-tests, qRT-PCR, western blots and FACS analysis were performed for analysis. The two cell lines presented different degrees of cell death upon irradiation. The radiosensitive cell line PCI-9A showed increased apoptosis after irradiation measured by expressed cleaved caspases 3 and 7 while the radioresistant cell line PCI-15 upregulated antiapoptotic Survivin and BCL2A1 mRNA. Besides, increased PI3K/AKT- and ERK1/2-signalling was associated with radioresistance accompanied by loss of PTEN function through phosphorylation on S380. Blockade of pAKT increased radiation-induced cell death, and moreover, led to an upregulation of pMET in the radioresistant cell line. The percentage of ALDH-positive tumour cells was markedly decreased after irradiation in the radiosensitive cell line. Functional apoptosis is mandatory for sensitivity to irradiation in head neck cancer cells. Upregulation of the AKT-pathway seems to be one reason for poor radioresponse. Activated MET may also predict radioresistance, possibly through ERK1/2 signalling. Moreover MET may indicate the presence of cancer stem cells facilitating radioresistance as shown by increased ALDH expression.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
十二烷基硫酸钠, BioReagent, suitable for electrophoresis, Molecular Biology, ≥98.5% (GC)
Sigma-Aldrich
十二烷基硫酸钠, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
DL-二硫代苏糖醇 溶液, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
十二烷基硫酸钠, ACS reagent, ≥99.0%
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, Molecular Biology, 10% in H2O
Supelco
DL-二硫代苏糖醇 溶液, 1 M in H2O
Sigma-Aldrich
十二烷基硫酸钠, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
乙二胺四乙酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
乙二胺四乙酸, anhydrous, crystalline, BioReagent, suitable for cell culture
Sigma-Aldrich
乙二胺四乙酸 溶液, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
十二烷基硫酸钠, BioUltra, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, 20% in H2O
Sigma-Aldrich
乙二胺四乙酸 二钠盐 溶液, BioUltra, pH 8.0, ~0.5 M in H2O
Supelco
十二烷基硫酸钠, dust-free pellets, suitable for electrophoresis, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
乙二胺四乙酸, 99.995% trace metals basis
Sigma-Aldrich
乙二胺四乙酸, BioUltra, anhydrous, ≥99% (titration)
Supelco
十二烷基硫酸钠, suitable for ion pair chromatography, LiChropur, ≥99.0%
Sigma-Aldrich
十二烷基硫酸钠, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠, ≥98.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
乙二胺四乙酸, purified grade, ≥98.5%, powder
Sigma-Aldrich
十二烷基硫酸钠, ≥90% ((Assay))
Sigma-Aldrich
十二烷基硫酸钠, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Sigma-Aldrich
乙二胺四乙酸, ≥98.0% (KT)
Sigma-Aldrich
乙二胺四乙酸, BioUltra, ≥99.0% (KT)
月桂基硫酸钠, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
十二烷基硫酸钠, BioReagent, suitable for electrophoresis, Molecular Biology, ≥98.5% (GC), free-flowing, Redi-Dri
Sigma-Aldrich
十二烷基硫酸钠, Vetec, reagent grade, ≥98%
Sigma-Aldrich
乙二胺四乙酸, Vetec, reagent grade, 98%